English / Français

stories » I am part of the DTG Story, Voices from Friends of MPP

#HIV is alive – Nombeko Mpongo talks about access to treatment

19 July 2024

Hope and Healing: Nombeko Mpongo’s Journey with HIV

Join Nombeko Mpongo, a resilient individual living with HIV in South Africa, as she shares her inspiring journey towards better health.

The Switch to TLD Treatment

In this testimonial, Nombeko discusses the life-altering access to HIV treatment and the profound difference dolutegravir has made in her life and for others, people can go to work more easily, take care of their family, read more and sleep without difficulties of side effects.

Future Challenges in the way of hopes becoming reality

She also touch on the next challenges to end the HIV epidemic and how civil societies can help. Her story is one of hope and empowerment.

Share page:

Bluesky

About Us

The Medicines Patent Pool (MPP) is a United Nations-backed public health organisation working to increase access to and facilitate the development of life-saving medicines for low- and middle-income countries. Through its innovative business model, MPP partners with civil society, governments, international organisations, industry, patient groups, and other stakeholders to prioritise and license needed medicines and pool intellectual property to encourage generic manufacture and the development of new formulations.

To date, MPP has signed agreements with 22 patent holders for 13 HIV antiretrovirals, one HIV technology platform, three hepatitis C direct-acting antivirals, a tuberculosis treatment, a cancer treatment, four long-acting technologies, a post-partum haemorrhage medicine, three oral antiviral treatments for COVID-19 and 16 COVID-19 technologies.

MPP was founded by Unitaid, which continues to be MPP’s main funder. MPP’s work on access to essential medicines is also funded by the Swiss Agency for Development and Cooperation (SDC), Government of Canada, the World Intellectual Property Organization (WIPO) and the Government of Flanders. MPP’s activities in COVID-19 are undertaken with the financial support of the Japanese Government, the French Ministry for Europe and Foreign Affairs, the German Agency for International Cooperation, and SDC.